about
Influence of CAG Repeat Polymorphism on the Targets of Testosterone ActionInstability of CTG repeats is governed by the position of a DNA base lesion through base excision repairAndrogen receptor CAG repeat length and risk of biliary tract cancer and stones.Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer riskInvolvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancerA 5', 8-cyclo-2'-deoxypurine lesion induces trinucleotide repeat deletion via a unique lesion bypass by DNA polymerase βTestosterone deficiency and mood in aging men: pathogenic and therapeutic interactions.Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer riskProstate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures.Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide.Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility.Trinucleotide repeat deletion via a unique hairpin bypass by DNA polymerase β and alternate flap cleavage by flap endonuclease 1.Sex steroid-related candidate genes in psychiatric disorders.Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer.Influence of androgen receptor repeat polymorphisms on personality traits in menCAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer.Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinomaAndrogen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis.Serum testosterone levels, testis volume, and the risk of prostate cancer: are these factors related?A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH.Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia.Race and Criminology in the Age of Genomic ScienceThe deoxyribose phosphate lyase of DNA polymerase β suppresses a processive DNA synthesis to prevent trinucleotide repeat instability
P2860
Q26784181-111A3FCA-E977-488F-90D8-67CC6FE6731BQ28486858-ACD98273-C1A0-40F6-A948-4C6107096C17Q33723560-F5BCDD78-EDE3-4A8E-9EA8-93C499E28209Q33938808-FB9A4284-EF36-4273-B386-23EB71085570Q33976024-C4F83484-DA21-472C-B6D4-5BC30A00FFD9Q34345107-7BAF1320-EDAF-4A98-A67C-EE4F517E0058Q34704983-6B36EE9E-284A-4F5A-8070-8E8A063B90E5Q34712058-168A1A80-6870-46F2-A292-1054D3DE3A15Q35064997-82A2978C-6037-4E8B-B226-DACCB0876A26Q35104856-2FD47A46-286B-4F3F-B371-879F0C8D73E4Q35823852-E02D74EB-AF4C-451F-8B9B-7E4263033728Q35828195-EFDD42BB-13FD-4170-BC1A-1D2D155F1E20Q36429591-99908770-1418-417A-A0D5-9EB77D30986AQ36580985-106FEDB4-B6D3-45DF-B69C-7A2748CDD064Q36737983-36FEA97C-993B-4D3B-AC13-3ACE8A6F029BQ37149323-0D3EE9CE-65A3-4F4D-AE21-50EE717764D5Q37173763-1D1E2EFD-C1C9-4E5C-9D22-17AF231F6690Q37181453-2FF5E3E3-FD30-4D04-A84D-A05A6B37DDC0Q37576761-99FE4399-B937-4D7C-A2CA-E8CF1428F138Q37587629-9B7F62B9-17CD-4A7D-8BD6-828364645173Q37594931-A738031E-CC3A-473B-A060-79E9748FA00BQ37701988-16794E2D-F3D1-41D2-BD12-BFCB278772B3Q37943460-41F2C206-5769-4E94-800F-BEDF49E499E8Q40309735-ED6D5868-1851-4C1B-8CAD-4751D4A566D4Q44992372-B278A180-941E-4957-B10A-637FE091111BQ45253544-99B0381D-4C8B-4769-9469-D8389849D673Q46429246-1997E3A2-4B2B-4B57-8E90-3C3928B68ED3Q47621371-9A7D1379-4C98-4062-A609-23F4E05C3022Q51491878-BDED69CB-C42A-4ABF-B0ED-B2610AB2F922Q54570685-A7FD2216-1C14-42A4-840B-7A555F96A9B9Q56060401-E25F7696-6900-41EA-99B8-7A74745BCAE3Q58802639-414E07B0-179E-4F27-8868-E056AF2834EE
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Androgen receptor CAG repeats and prostate cancer.
@ast
Androgen receptor CAG repeats and prostate cancer.
@en
Androgen receptor CAG repeats and prostate cancer.
@nl
type
label
Androgen receptor CAG repeats and prostate cancer.
@ast
Androgen receptor CAG repeats and prostate cancer.
@en
Androgen receptor CAG repeats and prostate cancer.
@nl
prefLabel
Androgen receptor CAG repeats and prostate cancer.
@ast
Androgen receptor CAG repeats and prostate cancer.
@en
Androgen receptor CAG repeats and prostate cancer.
@nl
P356
P1476
Androgen receptor CAG repeats and prostate cancer.
@en
P2093
John S Witte
Kevin A Nelson
P304
P356
10.1093/AJE/155.10.883
P407
P577
2002-05-01T00:00:00Z